433 related articles for article (PubMed ID: 19330474)
1. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not.
Wolk K; Haugen HS; Xu W; Witte E; Waggie K; Anderson M; Vom Baur E; Witte K; Warszawska K; Philipp S; Johnson-Leger C; Volk HD; Sterry W; Sabat R
J Mol Med (Berl); 2009 May; 87(5):523-36. PubMed ID: 19330474
[TBL] [Abstract][Full Text] [Related]
2. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression.
Tohyama M; Hanakawa Y; Shirakata Y; Dai X; Yang L; Hirakawa S; Tokumaru S; Okazaki H; Sayama K; Hashimoto K
Eur J Immunol; 2009 Oct; 39(10):2779-88. PubMed ID: 19731362
[TBL] [Abstract][Full Text] [Related]
3. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis.
Wolk K; Witte E; Warszawska K; Schulze-Tanzil G; Witte K; Philipp S; Kunz S; Döcke WD; Asadullah K; Volk HD; Sterry W; Sabat R
Eur J Immunol; 2009 Dec; 39(12):3570-81. PubMed ID: 19830738
[TBL] [Abstract][Full Text] [Related]
4. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.
Nograles KE; Zaba LC; Guttman-Yassky E; Fuentes-Duculan J; Suárez-Fariñas M; Cardinale I; Khatcherian A; Gonzalez J; Pierson KC; White TR; Pensabene C; Coats I; Novitskaya I; Lowes MA; Krueger JG
Br J Dermatol; 2008 Nov; 159(5):1092-102. PubMed ID: 18684158
[TBL] [Abstract][Full Text] [Related]
5. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M
Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
[TBL] [Abstract][Full Text] [Related]
6. Induction of PDGF-B in TCA-treated epidermal keratinocytes.
Yonei N; Kanazawa N; Ohtani T; Furukawa F; Yamamoto Y
Arch Dermatol Res; 2007 Nov; 299(9):433-40. PubMed ID: 17724602
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of Interferon-inducible protein 16 contributes to psoriasis by modulating chemokine production in keratinocytes.
Cao T; Shao S; Li B; Jin L; Lei J; Qiao H; Wang G
Sci Rep; 2016 May; 6():25381. PubMed ID: 27137868
[TBL] [Abstract][Full Text] [Related]
8. Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis.
Peng C; Zhang S; Lei L; Zhang X; Jia X; Luo Z; Huang X; Kuang Y; Zeng W; Su J; Chen X
Sci Rep; 2017 Mar; 7():44172. PubMed ID: 28272440
[TBL] [Abstract][Full Text] [Related]
9. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22.
Honma M; Minami-Hori M; Takahashi H; Iizuka H
J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341
[TBL] [Abstract][Full Text] [Related]
10. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
[TBL] [Abstract][Full Text] [Related]
11. Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells.
Kanda N; Kamata M; Tada Y; Ishikawa T; Sato S; Watanabe S
J Leukoc Biol; 2011 Jun; 89(6):935-44. PubMed ID: 21367976
[TBL] [Abstract][Full Text] [Related]
12. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
[TBL] [Abstract][Full Text] [Related]
14. Regulation of IL-33 expression by IFN-γ and tumor necrosis factor-α in normal human epidermal keratinocytes.
Meephansan J; Tsuda H; Komine M; Tominaga S; Ohtsuki M
J Invest Dermatol; 2012 Nov; 132(11):2593-600. PubMed ID: 22673732
[TBL] [Abstract][Full Text] [Related]
15. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.
Sa SM; Valdez PA; Wu J; Jung K; Zhong F; Hall L; Kasman I; Winer J; Modrusan Z; Danilenko DM; Ouyang W
J Immunol; 2007 Feb; 178(4):2229-40. PubMed ID: 17277128
[TBL] [Abstract][Full Text] [Related]
16. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
17. Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model.
Palombo R; Savini I; Avigliano L; Madonna S; Cavani A; Albanesi C; Mauriello A; Melino G; Terrinoni A
Cell Death Dis; 2016 Aug; 7(8):e2344. PubMed ID: 27537526
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice.
Kumari S; Bonnet MC; Ulvmar MH; Wolk K; Karagianni N; Witte E; Uthoff-Hachenberg C; Renauld JC; Kollias G; Toftgard R; Sabat R; Pasparakis M; Haase I
Immunity; 2013 Nov; 39(5):899-911. PubMed ID: 24211183
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
20. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.
Chiricozzi A; Guttman-Yassky E; Suárez-Fariñas M; Nograles KE; Tian S; Cardinale I; Chimenti S; Krueger JG
J Invest Dermatol; 2011 Mar; 131(3):677-87. PubMed ID: 21085185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
